Over the past decade, in-vivo MRI studies have provided many invaluable insights into the neural substrates underlying autism spectrum disorder (ASD), which is now known to be associated with neurodevelopmental variations in brain anatomy, functioning, and connectivity. These systems-level features of ASD pathology seem to develop diff erentially across the human lifespan so that the cortical abnormalities that occur in children with ASD diff er from those noted at other stages of life. Thus, investigation of the brain in ASD poses particular methodological challenges, which must be addressed to enable the comparison of results across studies. Novel analytical approaches are also being developed to facilitate the translation of fi ndings from the research to the clinical setting. In the future, the insights provided by human neuroimaging studies could contribute to biomarker development for ASD and other neurodevelopmental disorders, and to new approaches to diagnosis and treatment.
Introduction
Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder that develops in early childhood. It is diagnosed on the basis of a combination of behavioural observations and clinical interviews that assess defi cits in social communication, social reciprocity, and repetitive and stereotyped behaviours and interests. 1 These core symptoms of ASD typically manifest from around age 2 years and are accompanied by developmental diff erences in brain anatomy, functioning, and connectivity that aff ect behaviour across the lifespan. The causes of ASD are complex and include genetic and environmental risk factors. 2 For instance, on the genetic level alone, more than 100 genetic and genomic loci have been implicated in autism. 3 However, the ways in which these risk factors lead to the biological diff erences underpinning ASD or whether they could provide crucial clues to help in the development of new treatments is unknown.
In this Series paper, we review insights into atypical brain development across the human lifespan in ASD, and respective neurodevelopmental diff erences in brain anatomy, functioning, and connectivity within the neural systems that underlie specifi c autistic symptoms. Various neuroimaging techniques can been used to investigate the brain in vivo (eg, PET and magnetoencephalography), but most studies of the brain in ASD have used MRI, which provides the basis for our review. We discuss the potential for translation of in-vivo neuroimaging fi ndings from the research to the clinical setting. In particular, we focus on the clinical utility of multivariate pattern classifi cation approaches, which are becoming increasingly popular for the analysis of complex biological data to make clinically relevant predictions (eg, diagnostic category or clinical outcome). Despite the promise of such approaches, studies investigating the biomarker potential of neuroimaging measures for ASD have, so far, been confi ned to the research setting, and how well these approaches might work in the real-world clinical setting remains unknown.
Atypical brain development Early brain development
Findings from several structural MRI studies have shown that toddlers with ASD (age 2-4 years) have, on average, a larger brain volume than typically developing children (ie, those without a medical or psychiatric diagnosis). [4] [5] [6] However, this increased brain volume seems to disappear around the age of 6-8 years, when growth curves intersect; 5 after this, no substantial increases in total brain volume commonly occur. 7 These fi ndings, and others, contributed to the notion that the neurodevelopmental trajectory of brain maturation is atypical in ASD and includes a period of early overgrowth followed by arrested growth and possibly a decrease in brain volume at older ages. 7 Moreover, the altered neurodevelopmental trajectory of the brain in ASD seems to vary across diff erent brain regions, with the frontal and temporal lobes being aff ected more than the parietal and occipital lobes. 6 This fi nding suggests that the temporal and regional sequence of typical early brain development (ie, from back to front) 8 is perturbed in ASD. However, others have also reported generalised enlargements throughout the cerebral cortex in children with ASD between age 18 months and 35 months, 9 which will not only aff ect the structure of isolated brain regions, but also lead to diff erences in brain anatomy and connectivity on a systems level.
10 Some of the systemslevel abnormalities in an early-onset disorder such as ASD will probably diff er from those found in disorders that are usually present later in life (eg, schizophrenia). However, the stage in brain development during which the fi rst diff erences in brain anatomy and connectivity associated with ASD occur is poorly understood.
Findings from several longitudinal MRI studies of infants at high familial risk of developing ASD (eg, siblings of aff ected individuals) suggest that diff erences in the brain can already be seen in the fi rst 2 years of life. For example, Schumann and colleagues 11 reported brain Series enlargement in 2·5-year-olds with ASD, which was accompanied by an abnormally increased growth rate of the cortex. A general cerebral enlargement in ASD was also noted by Hazlett and colleagues 12 at this age; however, by contrast, this enlargement was not associated with an increased growth rate. Hence, there is compelling evidence that individuals with ASD have an early enlargement of the brain that is already visible at around age 2 years.
Whether this enlargement represents an ongoing accelerated growth of the cortex or is the end result of previous diff erences in brain growth remains unclear. Moreover, the pathological process that underpins diff erences in brain volume is unclear, although recent progress has been made. For instance, Hazlett and colleagues 12 did not identify an increase in cortical thickness and so argued that the increase in brain volume in ASD must be driven by an increase in brain surface area before the age of 2 years. The distinction between cortical thickness and surface area is important because both measurements are related to distinct aspects of cortical neuropathology and represent diff erent features of the cortical architecture.
In terms of phylogeny, cortical thickness and surface area are now widely believed to be determined by diff erent types of progenitor cells, which divide in the ventricular zone to produce glial cells and neurons. Cortical thickness has been related to intermediate progenitor cells, 13 which divide symmetrically at basal positions of the ventricular surface. These progenitor cells only produce neurons, 14, 15 which then migrate along radial glial fi bres to form ontogenetic columns arranged as radial units. According to the radial unit hypothesis, 16 cortical thickness is determined by the neuronal output from each radial unit amplifi ed by intermediate progenitor cells and, therefore, is related to the number of neurons produced in each unit. By contrast, cortical surface area has been associated mainly with radial unit progenitor cells, which divide at the apical ventricular surface. The early proliferation of radial unit progenitor cells leads to an increase in the number of proliferation units, which in turn increases the number of ontogenetic columns, resulting in increased surface area. 13 The fi nding of early enlargement of the brain in ASD, caused by an accelerated expansion of cortical surface area but not cortical thickness, 12 is hence of importance because it points towards specifi c genetic and neurobiological mechanisms that might be impaired in ASD, and highlights the need for the development of novel neuroimaging measurements that off er a higher degree of specifi city with regard to particular underlying mechanisms. Figure 1 shows the chronological progression of MRI measurements from volumetric features 4, [17] [18] [19] to surfacebased geometric measurements 10,20-23 of brain anatomy and diff usion tensor imaging measurements of structural brain connectivity. 24 These fi ndings support suggestions that the accelerated expansion of the cortical surface and a potential pathological change in the number or size of cortical neurons or minicolumns in ASD 25, 26 leads to the brain being connected diff erently; 27 for example, as evident in early white matter diff erences in ASD. 28 Thus, atypical development of the cortical grey matter in ASD is likely to be linked to abnormal maturation of the cortical white matter, and multimodal neuroimaging studies examining the relation between the development of cortical grey matter and white matter will be a crucial next step in the identifi cation of the mechanisms that drive perturbed brain maturation in ASD.
Findings from several recent studies have shown the importance of considering wider contextual issues when interpreting reports of early brain overgrowth in ASD. For example, in 2013, Raznahan and colleagues 29 suggested that the well-replicated fi nding of a signifi cant increase in head circumference in ASD-which accompanies the increase in total brain volume-might in fact be a result of a bias in population norms rather than a replicable pattern of dysregulated growth. 29 Future investigations into population norms will also be important when considering the large phenotypic diversity of the brain in ASD, which can only be reliably interpreted in the context of the wide neuroanatomical diversity within the general population. 30 Evidence also suggests that early brain overgrowth in ASD is not restricted to the brain exclusively, but that early generalised patterns of physical (ie, somatic) overgrowth occur in ASD, particularly in boys. 31, 32 Thus, dynamic changes in population norms and factors responsible for both neural and non-neural tissue development should be considered to provide a more comprehensive assessment of atypical brain development in ASD.
Neural systems underlying autistic symptoms and traits
The components of the neural systems that probably underlie ASD are well established and most likely incorporate the frontotemporal and frontoparietal regions, amygdala-hippocampal complex, cerebellum, basal ganglia, and anterior and posterior cingulate regions. 33 Moreover, these core regions have been suggested to mediate specifi c clinical symptoms. For example, abnormalities in (1) Broca's area and Wernicke's area have been associated with social communication and language defi cits; 34 (2) frontotemporal regions and the amygdala have been related to abnormalities in socio-emotional processing; 35, 36 and (3) the orbitofrontal cortex and the caudate nucleus (ie, frontostriatal system) might mediate repetitive and stereotyped behaviours. 37 Findings from a voxel-based morphometry study 38 suggest that the neuroanatomy of ASD is also modulated by sex, and might be related to gender diff erences in neurocognitive profi les. 39 Moreover, although abnormalities in these brain regions seem to be common in ASD, evidence suggests that the diff erences in these regions are not specifi c to the disorder. For example, neuroimaging evidence suggests that the Series caudate nucleus is enlarged in ASD, 40 and that this enlargement is associated with the severity of repetitive and stereotyped behaviours. 41 The amygdala is also signifi cantly enlarged in children with ASD compared with typically developing children. 42 However, enlargement of the basal ganglia has also been noted in individuals with obsessive-compulsive disorder without a comorbid diagnosis of ASD, 43 and increased total amygdala volume has been reported in children with general anxiety disorders. 44 Finally, frontal lobe abnormalities, which are a hallmark of ASD, have also been found in other neurodevelopmental disorders such as schizophrenia. 45 These fi ndings suggest that phenotypic similarities in brain anatomy between ASD and other psychiatric disorders might be related to similarities in their respective clinical phenotypes. However, future research is needed to establish the extent and origins of such shared neuroanatomical variation, and to establish whether there are common or distinct genetic and molecular mechanisms for similar symptoms across disorders.
Neurodevelopment across the human lifespan
Less is known about neurodevelopment during adolescence and adulthood in ASD. Although early brain development in ASD seems to be dominated by an accelerated increase in volume of the frontal and temporal lobes, 46 brain development after early adolescence seems to be dominated by an accelerated age-related decline in total brain volume 47 and its two constituents (ie, cortical thickness and surface area). For Figure 1 : Progression of structural MRI measurements over time as applied to autism spectrum disorder Imaging measurements are becoming increasingly more specifi c with regard to particular underlying neural mechanisms, which will help to further disentangle diff erent aspects of the cortical pathology of autism spectrum disorder in the future. Improvements in the specifi city of imaging measurements will also increase their translatability across disciplines (eg, combining imaging and genetic studies). Panel A reproduced from Courchesne, 4 by permission of Nature Publishing Group. Panel B reproduced from Herbert and colleagues, 17 by permission of Oxford University Press. Panel C reproduced from Schumann and colleagues, 18 by permission of the Society for Neuroscience. Panel D reproduced from Waiter and colleagues, 19 by permission of Elsevier. Panel E reproduced from Nordahl and colleagues, 20 by permission of the Society for Neuroscience. Panel F reproduced from Pugliese and colleagues, 24 by permission of Elsevier. Panel G reproduced from Hyde and colleagues. 21 Panel H reproduced from Ecker and colleagues, 22 by permission of the American Medical Association. Panel I reproduced from Wallace and colleagues, by permission of Oxford University Press. 23 Panel J reproduced from Ecker and colleagues, 10 by permission of the National Academy of Sciences of the USA.
• Area of a vertex on the grey matter surface • According to the radial unit hypothesis, areal measurements are closely related to the number of cortical minicolumns Series example, accelerated cortical thinning in various brain regions in ASD has been reported in several crosssectional MRI studies, 48 and has been confi rmed in a large longitudinal study of individuals aged 3-39 years. 49 Additionally, measurements of surface area decline more rapidly with age in individuals with ASD than in those without ASD both at the global (ie, total surface area) 50 and the local (ie, vertex wise) 51 levels. These fi ndings also highlight the importance of accounting for the diff erent neurodevelopmental stages when comparing individuals with ASD with typically developing controls because the rate of cortical development is not linear across the human lifespan, and precocious or delayed maturation in a group of individuals could lead to a substantial positive diff erence at one age and a substantial negative diff erence at another age. 48 For example, the amygdala is enlarged in toddlers and children with ASD, whereas no signifi cant diff erences have been reported in adolescents with the disorder. 18, 52 Thus, general eff ects of age and ageby-group interactions need to be accounted for in the statistical model when examining neuroanatomical variations across the human lifespan. However, overall, fi ndings from neuroimaging studies suggest that atypical cortical development in ASD occurs in distinct stages that are dominated by an accelerated expansion of the cortical surface during childhood, and there is initial evidence that this expansion is followed by an acceleration in cortical thinning during adolescence and adulthood. If correct, these fi ndings suggest that individuals with ASD might be at risk for accelerated cortical decline in later life. Hence, in the future, large normative datasets characterising the developmental timecourse of diff erent morphometric features in diff erent brain regions will be needed to fully characterise the cortical ontogeny of ASD. Moreover, in addition to investigating volumetric features of brain anatomy, examination of diff erences in geometric features (eg, cortical folding) in ASD will also be important.
Atypical cortical gyrifi cation
If we accept that in ASD the brain undergoes a stage of accelerated expansion during childhood, 12 we can also expect the brain to diff er in geometry from those without ASD. As the cortex expands, it eventually needs to fold to fi t an increasing brain surface into the fi nite space of the skull. Consequently, the brain in ASD would be expected to show an increase in cortical folding. 12 The investigation of cortical folding would also allow us to better defi ne the causative mechanisms associated with ASD. For example, axonal white matter fi bres might exert a pulling force on the overlying neocortex, and so might modulate cortical folding extrinsically via mechanical tension. 53 Alternatively, cortical folding might be mediated by developmental changes intrinsic to the cortical sheet (ie, within the cortical grey matter). For instance, the formation of cortical gyri has been linked to an accelerated expansion of the outer cortical layers relative to the deeper layers 54 and to the microstructural complexity of the associated grey matter determined by dendritic arborisation, synaptogenesis, and the alignment of neurons in space. 55 In other words, studies of cortical folding allow us to better defi ne the cellular and microstructural processes underpinning diff erences in brain development, and in particular those of relevance to ASD.
Atypical cortical gyrifi cation in the brain of individuals with ASD has been reported in several MRI studies, most of which involved manual assessments of the cortical surface. For example, a signifi cantly higher incidence of cortical malformations have been reported in patients with ASD compared with healthy controls, including (1) polymicrogyria (too many small folds, thought to arise from atypical prenatal brain maturation); (2) schizencephaly (clefts lined within the cortical grey matter); and (3) macrogyria (increased size of gyri). 56 Evidence also suggests that some sulci (eg, the Sylvian fi ssure) seem to be further along the principal axes of the brain in children with ASD than in those without ASD, 57 and that there is signifi cantly increased gyrifi cation of the frontal lobe in children and adolescents with ASD. 58 These early neuroimaging studies are supported by investigations using automated techniques that provide measurements for gyrifi cation in a spatially unbiased fashion. For example, an increasing number of studies have investigated brain morphology using a measurement known as the local gyrifi cation index-a local variant of the classic twodimensional gyrifi cation index. 59 The local gyrifi cation index at a given point on the cortical surface represents the amount of cortex buried within the sulcal folds and is computed as the ratio between the surface of a circular patch on the outer, smooth surface of the brain and the surface of the corresponding patch on the pial (ie, grey matter) surface (fi gure 2A). 60, 62 In males with ASD compared with typically developing male controls aged 12-23 years, the local gyrifi cation index is increased in bilateral posterior brain regions (fi gure 2B). 23 The local gyrifi cation index is signifi cantly reduced in the left supramarginal gyrus in males aged 8-40 years 63 and in the right inferior frontal and medial parieto-occipital cortices in children with ASD (fi gure 2C). 61 Although these divergent fi ndings can be partially explained by diff erences in sample size, participant demographics, and analytical techniques (eg, size of smoothing kernel), evidence also suggests that the particular pattern of cortical gyrifi cation is variable across individuals-even in normative populationsand that both genetic and non-genetic factors contribute to patterns of cortical folding. 64 For instance, Kates and colleagues 65 directly examined the amount of concordance in gyrifi cation index in monozygotic twin pairs in which one twin had a diagnosis of ASD and in typically developing unrelated controls. They reported a high level of discordance in cortical folding within ASD twin pairs across most lobular regions of the cortex, but Series both children with ASD and their co-twins exhibited increased parietal lobe cortical folding compared with controls. 65 Thus, although patterns of cortical folding might be suggestive of an atypical neurodevelopmental trajectory driven by various genetic and molecular processes, environmental factors and experiencedependent mechanisms also probably modulate cortical morpho metry, and perhaps especially cortical folding. This fi nding is in contrast to conventional measurements of brain anatomy (eg, total or regional brain volume), which are highly concordant between twins, and might thus be largely genetically determined. 66 Hence, future studies of the genetic and environmental factors that aff ect brain development in ASD will probably need to include measurements of cortical geometry in addition to those of volume. The examination of geometric features of the brain is of increasing importance in view of uncertainty about the heritability of ASD. For example, although in a traditional twin study the heritability of ASD (ie, proportion of liability attributable to genetic factors) was estimated at about 90%, 67 fi ndings from a 2011 study 2 suggested that susceptibility to ASD has moderate genetic heritability (38%), with a large proportion of variance in liability explained by shared environmental factors (58%). Thus, to elucidate the contribution of genetic and non-genetic factors to brain development in ASD, various cortical features, including shape characteristics of the brain, should be examined to account for the large amount of phenotypic inter-individual variability typically noted in the brain in ASD.
Neural activation and functional connectivity
In view of the abnormal development of grey and white matter in autism, aff ected brain regions will inevitably be unable to generate connections that give rise to fully eff ective functional networks. Early functional MRI (fMRI) investigations focused exclusively on regionspecifi c diff erences in the magnitude of activation. Because fMRI studies use diff erent activation paradigms and task parameters, often in cohorts with diff erent ages and levels of severity, results vary markedly. Results from face processing studies provide a stark example of the profound eff ects that minor task diff erences will produce; for example, early studies examining neural responses to emotional faces initially showed reduced activation in face-specifi c perceptual regions [68] [69] [70] in addition to limbic areas, particularly the amygdala. 71, 72 However, further examination showed that activation diff erences between typically developing individuals and those with ASD were strongly aff ected by experimental factors such as gaze direction 73 and face familiarity. 74 Nonetheless, consistent diff erences in brain activation occur in regions that also show structural abnormalities, as highlighted in several recent reviews. [75] [76] [77] Findings from many studies have shown decreased activation in regions comprising the social brain network during tasks related to emotional processing or social cognition, including the amygdala, temporal-parietal junction, insula, and inferior frontal cortex; 71, [78] [79] [80] [81] [82] [83] [84] in frontostriatal circuitry in response to cognitive control tasks and repetitive behaviours; 75, [85] [86] [87] [88] in language circuitry during communication tasks; [89] [90] [91] and in reward circuitry. [92] [93] [94] [95] By contrast, abnormal increases in Series activation are found in response to irritants and direct gaze. 96, 97 Taken together, these fi ndings strongly support a link between regional structural brain abnormalities and functional sequelae, including both regional brain activation and phenotypic presentation.
In other studies, neural activity has been examined at the network level, focusing on brain connectivity either during task performance or in the resting state (panel; fi gures 3 and 4). [99] [100] [101] In most fMRI studies in people with autism, functional connectivity during task performancemeasured by examining the correlation of fMRI activation changes between brain regions in typically developing participants versus those with ASD-is decreased. Such studies have typically included only high-functioning older participants. By contrast, resting-state fMRI examines spontaneous fl uctuations in brain activity, measuring diff erences in the correlation between regions in welldefi ned functional networks. These studies have yielded mixed results, and there remains substantial controversy regarding the nature of connectivity impairment in autism, with researchers arguing in favour of under-connectivity, 102 over-connectivity, 103, 104 or unique patterns of both underconnectivity and over-connectivity depending on the brain region. 105 Among the reasons for diff erences between studies are diff erences in the severity of ASD and, in fMRI activation studies, variable task choices, such as the choice of the smoothing fi lter or template. Choices in subtle aspects of image processing can also aff ect results. 106 Furthermore, fi ndings from a 2013 review suggested that connectivity results are aff ected by the age of the population studied. 107 Thus, the nature and direction of connectivity diff erences in ASD might change across the lifespan.
Applications of graph theoretical approaches in ASD
Graph theoretical approaches can be used to identify new ways to describe the nature of both local and global network function, and can be applied to structurally or functionally defi ned networks; these approaches are also increasingly used to investigate connectivity impairments in ASD. These techniques describe properties of network dynamics that make up well-integrated biological systems and include metrics such as (1) modularity,
Panel: Network analysis of brain connectivity
Resting-state functional MRI (fMRI) takes advantage of spontaneous low-frequency fl uctuations in cerebral blood fl ow to measure correlations within and between brain regions. 98 Resting-state fMRI studies have identifi ed networks of brain areas with similar levels of spontaneous activity at rest-such as sensorimotor, visual, and auditory systems; a language network, attention networks, and the default mode network; and a series of regions including the precuneus, medial frontal cortex, and hippocampus-that tend to show cerebral blood fl ow decreases during cognitive performance, but with relative increases at rest. Nodes in these networks can be identifi ed in several ways-for example, by using a priori anatomical regions of interest or functional masks derived from previous studies of resting-state activity identifi ed by independent components analysis. Graph theory analyses use all identifi ed nodes and enter them into a correlation matrix. The data entering the correlation matrix can come from any modality, such as cortical thickness from structural MRI, fractional anisotropy from diff usion tensor imaging, temporal correlation coeffi cients from spontaneous fl uctuations in resting-state fMRI, or activation in task-based fMRI. Graph analyses can be used to examine correlations within and between networks, and a wide range of metrics, some of which are interdependent, describe the properties of the networks derived from the correlation matrices. Figure 3 details a typical analysis pathway to derive a connectivity matrix from resting-state fMRI. 99 From this basic structure, several aspects of the resulting networks can be examined, including the extent to which specifi c regions form a correlated matrix that is separate from others (modularity); the number of connections needed to travel from one node to another (effi ciency); and the extent to which specifi c nodes form hubs. Figure 4A shows the network structure of fi ve modules derived from a resting-state fMRI study. 100 The investigators optimised this analysis to identify functional modules by fi nding the best structure that maximally separated modules from one another while maximising correlations within nodes. The modules were consistent with combined somatosensory and auditory, attention, visual, default mode, and limbic, paralimbic, and subcortical networks. This pattern shows the hallmarks of a typical biological network: (1) there are distinct modules in which regions within the modules are highly connected to each other, and nodes within each module are locally effi cient (there are direct paths from one node to another); and (2) the modules are distinctly segregated from one another, and there are few connections between the modules, so that the connections are clearly segregated. As a general rule, more paths would be needed for a node in one module to reach a node in another. A few regions seem to be hubs, connecting to several diff erent modules. Only a few characteristics of a well-formed biological network enable specialisation of function, communication, and integration of information across networks that is effi cient, non-random, and well organised. In the largest resting-state study in autism spectrum disorder (ASD) so far 101 -a multisite study combining images from 703 children and adolescents (360 with ASD and 403 with normal development)-widespread reductions in connectivity were reported among children with autism, spanning unimodal, heteromodal, primary somatosensory, and limbic and paralimbic cortices, whereas those with ASD had increased connectivity between a small set of nodes primarily in subcortical regions (fi gure 4B). This pattern of results supports a model of abnormal neurodevelopmental trajectories in ASD while providing a background for understanding various cognitive processing defi cits.
Series which shows the extent to which clusters of regions are associated with one another and are segregated from other modules; (2) local effi ciency, which describes how effi ciently local regions can communicate together; and (3) global effi ciency, which refers to how densely regions across the brain are connected to one another. 108 Network analysis during resting-state fMRI in ASD has yielded controversial results, mainly because some crucial metrics, including local versus global effi ciency, are sensitive to motion artifacts. 109 Because children with ASD diff er from typically developing children in their ability to self-regulate behaviour, increased motion in patients compared with controls could introduce a systematic bias, with apparent diff erences in functional connectivity resulting from motion artifacts. Similar confounds occur in diff usion tensor imaging studies. 110 In a recent study of a small sample of individuals with ASD, no global and only slight local diff erences in functional connectivity were noted when head motion was carefully eliminated by scrubbing or removing images aff ected by motion from the data. 111 However, fi ndings from most studies have continued to support the broad notion that, overall, individuals with ASD have poorer connectivity in regions spanning long distances in the brain than do typical controls, whereas connectivity seems to be increased in local circuits. 92, [112] [113] [114] Furthermore, important properties of network connectivity seem to be altered in ASD; for example, the development of domain-specifi c function modules is reduced. 115, 116 Although local connectivity within central hubs or rich clubs (ie, high-degree nodes that are more densely connected among themselves than nodes of a lower degree) seems to be increased, 117 the hub organisation is altered across the brain. 118 Taken together, fi ndings from functional activation and functional connectivity studies suggest that, in children with autism, widespread patterns of developmental disconnection aff ect information processing at both the local and global levels; furthermore, the specifi c patterns of connectivity abnormalities relate to the severity of the autism phenotype.
Genetic risk factors for ASD and their association with measures of brain activation and connectivity
Findings from recent studies have linked genetic risk for autism to diff erences in functional brain activation and connectivity. Broadly, these imaging-genetics studies examined syndromes that carry a high risk for autism, such as fragile X, 15qdup, 22q11.2 deletion, and Angelman's syndrome, or investigated specifi c candidate risk genes more broadly in the population. Because patients with syndromic autism more commonly have marked cognitive dysfunction than do neurotypical controls, few fMRI studies have included these populations because of their reduced ability to actively participate and engage in tasks within the constrained fMRI environment. A few exceptions have been studies of fragile X 119-121 and 22q11.2 deletion syndrome. 122, 123 Although results vary, in general, comparisons of syndromic autism versus controls yield similar results to those of ASD versus controls with regard to reduced connectivity, brain overgrowth, and abnormal functional activation, although a few consistent diff erences, particularly enlarged caudate volumes and caudate connectivity, seem to be specifi c to these syndromes.
Unlike studies of syndromic autism, the common polymorphism approach is used to examine the eff ects of autism risk genes independent of diagnosis, and thus has fewer confounds with variables such as impaired cognition. In several studies, associations have been reported between autism risk genes and brain connectivity. 
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For instance, the gene CNTNAP2, which confers risk for selective language impairment and for the language phenotype in autism, 124 is associated with abnormal structural and functional connectivity, 125, 126 and specifi cally a pattern of increased short-range and decreased longrange connectivity. 92 Variations in oxytocin receptor genes, which confer a risk for autism, have been associated with diff erences in both amygdala volume 127 and functional connectivity of the hypothalamus. 128 Similarly, the MET promoter variant-another autism risk gene-is related to both increased functional activation and decreased functional connectivity in neural networks associated with the processing of facial aff ect. 115 Taken together, studies that have examined the relation between genes associated with autism and brain structure and function support a model of abnormal developmental connectivity that leads to both reduced functional activation and decreased development of functional connections, particularly in long-range pathways; these diff erences occur in individuals who carry autism risk genes but who do not have autism.
Recent use of network analysis of gene expression profi les in tissue from patients with autism taken at post mortem 129 suggest the potential to better link genes and brain development in autism. Because network analysis is independent of modality, these techniques off er the potential to combine functional and structural imaging results, providing a comprehensive and potentially integrative model linking anatomical abnormalities to functional and phenotypic outcomes.
MRI-driven biomarker development
Typical brain development occurs as a dynamic yet ordered sequence of temporally distinct regional events, 8 which, if perturbed, would not only aff ect the development of isolated brain regions, but also lead to diff erences in brain anatomy and connectivity at the systems level. 130, 131 Thus, multivariate approaches that off er high exploratory power by taking advantage of the correlated structure (ie, covariations) in a large and potentially complex (ie, multimodal) set of variables are particularly well suited to the investigation of the complex cortical pathology of ASD. Moreover, some multivariate techniques also enable researchers to make clinically relevant predictions. In the context of MRI, these techniques have been described as brain-decoding methods, 132 and they belong to a wider group of techniques known collectively as machine learning or multivariate pattern classifi cation. The basic 
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idea of machine learning is to train a computer algorithm to identify a complex pattern of data that can then be applied to new individuals to make a prediction. Training usually occurs in a well-characterised sample by fi nding a boundary, or hyperplane, that best discriminates between diff erent classes (eg, patients and controls). Once the classifi er is trained, it can then be used to predict group membership of a new test example (eg, a new individual with unknown group membership; fi gure 5). A key feature of pattern classifi cation is its potential to detect global, complex, and potentially multimodal patterns of abnormalities that cannot be effi ciently identifi ed with univariate methods. This aspect makes machine-learning approaches particularly suited to the search for autism biomarkers for case identifi cation, patient stratifi cation, or for the prediction of clinical outcomes.
Diagnostic methods for ASD and their limitations
At present, diagnosis of ASD is based on behavioural fi ndings, clinical interviews, or both, and does not include the use of biomarkers. Although behavioural diagnosis of ASD is advantageous in the clinical setting because it can accommodate all variations of the autism spectrum regardless of their cause, it is insuffi cient to separate potentially diff erent biological subgroups or strata of patients that would be expected to respond well to a particular treatment. Evidence suggests that there is a large amount of genetic, phenotypic, and clinical heterogeneity among individuals with ASD. For example, preliminary evidence suggests that about 30% of people with ASD might have hyperserotonaemia 133 and thus are likely to respond well to drugs that modulate the serotonergic system, whereas about 70% do not, which could also explain the low treatment response to serotonergic drugs in large-scale clinical trials. Thus, ASD probably cannot be treated with a one-size-fi ts-all approach; treatment needs to be more personalised and individually tailored. 134 Also, diagnosis of ASD on the basis of behavioural fi ndings can be problematic, particularly in adult populations. At present, ASD is diagnosed with the help of two assessment instruments: the Autism Diagnostic Interview-Revised (ADI-R) 135 and the Autism Diagnostic Observation Schedule (ADOS). 136 The ADI-R is a semi- In the testing phase, these patterns can then be applied to predict group membership of a new dataset. The separating hyperplanes are described by a learning weight vector, w, which shows the contribution of each voxel to the overall discrimination, and an off set, b.
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New case Series standardised interview typically done with parents of individuals with ASD and assesses the severity of autistic symptoms at the age of 4-5 years, which qualifi es for a diagnosis of childhood autism. The ADOS is a semi-structured assessment designed for use with the individual to be diagnosed and assesses the severity of present autistic symptoms. Thus, the use of either the ADI-R or the ADOS can be problematic for diagnosis of ASD in adult populations because (1) ADI-R assessments rely on the availability and reliability of an informant to give retrospective accounts of past autistic symptoms, which, in some cases, occurred many years ago; and (2) symptoms assessed in adult samples are often masked by coping strategies developed across the lifespan, and might have been alleviated by treatments and interventions. Thus, the availability of biomarkers that could assist behavioural diagnosis would be invaluable, particularly in cases in which behavioural accounts are insuffi cient to make a reliable diagnosis of ASD.
Applications of multivariate pattern classifi cation
An increasing number of studies are using multivariate pattern classifi cation techniques in the research setting to separate individuals with ASD from typically developing controls (ie, for case identifi cation), and proof-of-concept studies were originally done in adult samples. For example, Ecker and colleagues 137 explored the diagnostic value of whole-brain structural MRI scans measuring regional grey and white matter volume for ASD using a common variant of machine learning, the support vector machine (SVM). In this sample, the SVM correctly classifi ed individuals with ASD and controls into their respective diagnostic category on the basis of their neuroanatomy with about 80% accuracy. In addition to the binary classifi cation, the SVM provided a test margin for each participant, showing the level of confi dence with which a new individual could be classifi ed. 137 The test margins were also positively associated with the severity of autistic symptoms, thus suggesting that the SVM could be used to capture ASD along a continuum that is also apparent in its neuroanatomical imprint. These original observations, which provided initial proof of concept, are supported by fi ndings from several other neuroimaging studies with similar levels of classifi cation accuracy in younger age groups, 138 females with ASD, 139 and autism-related disorders, 140 and with various anatomical and functional measurements. 141 Therefore, in cases in which diagnostic data for behavioural assessments are insuffi cient for a diagnosis of ASD, biomarkers might provide additional valuable information that could aid the expert clinical assessment of ASD.
Recent advances in analytical techniques now also make possible the prediction of quantitative outcomes, rather than simple binary categories (eg, patients vs controls, or responders vs non-responders). For instance, in 2013, Sato and colleagues 142 used support vector regression to predict the severity of autistic symptoms as measured with the ADOS using inter-regional correlations of cortical thickness measurements in a sample of individuals with ASD. The implementation of such quantitative (ie, dimensional) approaches in machine learning is crucial for the development of ASD biomarkers, which should act as a quantitative measure of a biological mechanism rather than simply testing for the existence or absence of a pathological phenotype. Moreover, ASD is a complex disorder with many causes and comorbid conditions, and a large amount of variability in the type and severity of systems expressed by diff erent individuals. Thus, ASD is unlikely to be linked to a single biomarker (eg, an individual gene or brain region). Instead, ASD biomarkers are probably complex and multivariate, incorporating data from diff erent biological processes as well as diff erent measures for similar aspects of neurobiology. However, although the effi ciencies of diff erent data types have been compared with each other (eg, imaging vs genetics), 143 noone has yet managed to meaningfully combine data across disciplines to assess their predictive value for ASD.
Although pattern-classifi cation approaches hold promise for various clinical applications in ASD, several crucial issues must be addressed before these methods can be used in clinical practice, and to justify the increased costs of clinical MRI relative to the behavioural diagnosis. Most importantly, the extent to which automated classifi ers can be used to generalise to the real-world clinical setting, in which clinicians are confronted with many psychiatric populations in addition to individuals with ASD and typically developing controls, remains to be established. In the future, identifi cation of the clinical validity of these models using testing data from independent samples (ie, independent of the training set) that were acquired in the real-world clinical setting will be important. Furthermore, establishment of their clinical specifi city will be crucial-ie, although the established methods might be successful in distinguishing individuals with ASD from typically developing controls, they might not be able to distinguish ASD from the various related comorbid conditions (eg, attention defi cit hyperactivity disorder [ADHD], obsessive-compulsive disorder, or emotional disorders). 144 Pre liminary evidence suggests that the clinical specifi city of a classifi er increases with its overall accuracy. For instance, Ecker and colleagues 145 showed that a classifi er that is highly accurate for ASD did not allocate individuals with ADHD to the diagnostic category for cases but to the category of typically developing controls, whereas a classifi er that did no better than random for individuals with ASD also randomly allocated individuals with ADHD to the two available categories (ie, ASD and control groups). This fi nding suggests that a classifi er with high accuracy for ASD is also expected to be highly specifi c for the disorder. Finally, several technical limitations will have to be overcome before making automated approaches Series more widely available. For various reasons, including hardware-related eff ects such as radiofrequency coil sensitivity and electronic amplifi er gains, conventional structural MRI scans are not compatible across sites. Hence, a classifi er that is highly accurate for ASD at one scanning site might not necessarily be highly accurate for classifying ASD at another site. This issue is also a problem for functional neuroimaging data acquired at several sites or on diff erent scanner platforms. 146, 147 Thus, the standardisation of multi variate classifi cation approaches across sites or platforms at the level of data acquisition or image analysis, or both, will substantially contribute to the generalisability and availability of MRI-assisted classifi ers for ASD in the future.
Conclusions
Over the past two decades, neuroimaging studies have provided many important insights into the pathological changes that occur in the brain in ASD in vivo. Most importantly, they have shown that ASD is accompanied by an atypical trajectory of brain maturation, which gives rise to diff erences in neuroanatomy, functioning, and connectivity within the wider neural systems that probably mediate autistic symptoms and traits. However, the development of the brain in ASD is complex and is mediated by many genetic and environmental factors, and their interactions. Hence, in the future, establishment of the specifi c environmental risk factors that contribute to ASD susceptibility in addition to genetic variations will be crucial. Moreover, investigation of the neurobiological and clinical phenotype of ASD compared with various neurodevelopmental disorders will be important to delineate the shared versus distinct molecular mechanisms that might be used to identify novel treatment targets, or to develop stratifi cation instruments that can defi ne more biologically meaningful subgroups within clinically and biologically heterogeneous disorders. Although substantial progress has been made in the development of animal models and cellular assays, neuroimaging approaches remain one of the few techniques that allow us to directly examine the brain in vivo, and will probably facilitate the development of a more personalised, individually tailored approach to the treatment of ASD.
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Search strategy and selection criteria
We searched Medline and PubMed for original articles published between 1960 and Jan 4, 2015, that focused on autism. We used the following search terms: "autism", "neuroimaging", "brain functioning", "connectivity", "biomarkers", "brain anatomy", "graph theory", and "resting state" alone and in combination. We restricted fi ndings to reports written in English and included only full-text papers. We included only studies done in human beings. We searched the reference lists of identifi ed articles for further relevant publications. Publications were selected for inclusion on the basis of their relevance to the topic, originality, and the extent to which the study results were deemed to contribute to the published work on neuroimaging in autism spectrum disorders.
